Cargando…
Crosstalk between the M(1) muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?
Alzheimer's disease (AD) is a neurodegenerative disorder which accounts for 60–70% of the 50 million worldwide cases of dementia and is characterised by cognitive impairments, many of which have long been associated with dysfunction of the cholinergic system. Although the M(1) muscarinic acetyl...
Autores principales: | Thompson, Karen J., Tobin, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184673/ https://www.ncbi.nlm.nih.gov/pubmed/31978506 http://dx.doi.org/10.1016/j.cellsig.2020.109545 |
Ejemplares similares
-
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
por: Dwomoh, Louis, et al.
Publicado: (2022) -
Crystal structure of the M(5) muscarinic acetylcholine receptor
por: Vuckovic, Ziva, et al.
Publicado: (2019) -
M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer’s disease pathology
por: Yi, Jee Hyun, et al.
Publicado: (2020) -
Allosteric Modulation of Muscarinic Acetylcholine Receptors
por: Gregory, Karen J, et al.
Publicado: (2007) -
Structure and Dynamics of the M(3) Muscarinic Acetylcholine Receptor
por: Kruse, Andrew C., et al.
Publicado: (2012)